Validation of Risk of Chemotherapy-Induced Neutropenia: Experience from Oncology Hospital of Nepal

BACKGROUND: The majority of cancer patients undergoing chemotherapy show neutropenic condition which is a common side effect of myelosuppressive chemotherapy diagnosed as the reduced complete blood cell count. Such cancer patients have a higher risk of febrile neutropenia. The present study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapkota, Binaya, Shrestha, Ronash, Chapagai, Safin, Shakya, Dip Kiran, Bista, Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246329/
https://www.ncbi.nlm.nih.gov/pubmed/32547211
http://dx.doi.org/10.2147/CMAR.S243916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246329/
https://www.ncbi.nlm.nih.gov/pubmed/32547211
http://dx.doi.org/10.2147/CMAR.S243916

Ejemplares similares